Kyle Griffin @kylegriffin1
Kaiser Permanente has restricted the lupus and rheumatoid arthritis treatment hydroxychloroquine amid a national shortage, prompted by the drug's potential to treat the coronavirus. "We face the real possibility of running out of the drug." https://t.co/dMKjULViGe — PolitiTweet.org